KRKA d.d., Novo mesto, Slovenia.
Eur J Pharm Biopharm. 2012 Oct;82(2):376-82. doi: 10.1016/j.ejpb.2012.07.011. Epub 2012 Aug 1.
The absorption and bioavailability of drugs can be substantially affected by the transit of dosage forms through the gastrointestinal (GI) tract. Gastric emptying is one of the most critical parameters contributing to this inter- and intra-individual GI transit variability. It is especially important for the delayed release dosage forms whose release depends on the local environment and begins when the dosage form passes pylorus and comes into contact with higher pH medium in small intestine. The purpose of our research work was to predict the in vivo dissolution from enteric coated pellets for population and establish a good in vitro/in vivo correlation (IVIVC) with mean in vivo absorption profiles, obtained in a pharmacokinetic study under fasting conditions. The dissolution tests were carried out on a USP 4 - flow-through cell with enteric coated pellets containing an acid-labile drug and formulated as orodispersible tablets. Using several residence times in an acidic medium, we simulated the gastric emptying of the pellets and the exposure of different fractions of the pellets to the gastric medium for different periods of time. The amount of drug released decreased with the increasing time of exposure to the acidic medium due to the drug's degradation. The mean in vivo dissolution profiles, which were predicted on the basis of experimentally determined dissolution profiles and mathematical model of pellets' gastric emptying, gave a very good IVIVC with the mean in vivo absorption profiles.
药物的吸收和生物利用度会受到剂型在胃肠道(GI)中通过的影响。胃排空是导致这种个体间和个体内 GI 转运变异性的最重要参数之一。对于延迟释放剂型尤其重要,其释放取决于局部环境,并且当剂型通过幽门并与小肠中较高 pH 介质接触时开始。我们研究工作的目的是从肠溶包衣丸预测体内溶解情况,并与空腹条件下药代动力学研究中获得的平均体内吸收曲线建立良好的体外-体内相关性(IVIVC)。在 USP4 流动池上进行了包含酸不稳定药物的肠溶包衣丸的溶解试验,并将其制成口腔分散片。通过在酸性介质中使用不同的停留时间,我们模拟了丸剂的胃排空和丸剂的不同部分暴露于胃介质的不同时间段。由于药物降解,暴露于酸性介质的时间增加,药物释放量减少。基于实验确定的溶解曲线和丸剂胃排空的数学模型预测的平均体内溶解曲线与平均体内吸收曲线给出了非常好的 IVIVC。